July 25, 2019
FDA issues final guidance for drug-device combo products
The Food & Drug Administration (FDA) on July 22 issued a final guidance for makers of products that combine devices and drugs or biologics.
The guidance clarifies how manufacturers should comply with recordkeeping requirements and how they should submit safety reports and avoid duplication.
Read More >>
© 2019 Access Intelligence, LLC – All Rights Reserved. Reproduction in whole or in part in any form or medium without expressed written permission of Access Intelligence, LLC is prohibited. OR Manager is a registered trademark of Access Intelligence, LLC.